2018-2023 United States Cancer Treatment Drugs Market Report (Status and Outlook)

Publisher Name :
Date: 10-Oct-2018
No. of pages: 88

In 2017, the Cancer Treatment Drugs market size was xx million USD in United States, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023.

In United States market, the top players include

- Roche

- Novartis

- Celgene

- Bristol-Myers Squibb

- Amgen

- Johnson & Johnson

- Pfizer

- Takeda

- Eli Lilly

- AstraZeneca

- Astellas

- Merck & Co.

- Sanofi

- Bayer

- Biogen Idec

- Eisai

- Teva

- Otsuka

- Merck KGaA

- Ipsen

- AbbVie

- Gilead Sciences

Split by product types/category, covering

- Chemotherapy

- Targeted Therapy

- Immunotherapy

- Hormonal Therapy (Biologic Therapy)

- Others

Split by applications/end use industries, covers

- Blood Cancer

- Breast Cancer

- Gastrointestinal Cancer

- Prostate Cancer

- Respiratory/Lung Cancer

- Other Cancers

2018-2023 United States Cancer Treatment Drugs Market Report (Status and Outlook)

Table of Contents

2018-2023 United States Cancer Treatment Drugs Market Report (Status and Outlook)
1 Cancer Treatment Drugs Market Overview
1.1 Product Overview and Scope of Cancer Treatment Drugs
1.2 Cancer Treatment Drugs Market Segment by Types
1.2.1 United States Cancer Treatment Drugs Sales Present Situation and Outlook by Types (2013-2023)
1.2.2 United States Cancer Treatment Drugs Sales Market Share by Types in 2017
1.2.3 Chemotherapy
1.2.3.1 Major Players of Chemotherapy
1.2.4 Targeted Therapy
1.2.4.1 Major Players of Targeted Therapy
1.2.5 Immunotherapy
1.2.5.1 Major Players of Immunotherapy
1.2.6 Hormonal Therapy (Biologic Therapy)
1.2.6.1 Major Players of Hormonal Therapy (Biologic Therapy)
1.2.7 Others
1.2.7.1 Major Players of Others
1.3 United States Cancer Treatment Drugs Market Segment by Applications/End Use Industries
1.3.1 United States Cancer Treatment Drugs Sales Present Situation and Outlook by Applications/End Industrials (2013-2023)
1.3.2 United States Cancer Treatment Drugs Sales Market Share by Applications in 2017
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Respiratory/Lung Cancer
1.3.7 Other Cancers
1.4 United States Cancer Treatment Drugs Overview and Market Size (Value) (2013-2023)
1.4.1 United States Market Cancer Treatment Drugs Overview
1.4.2 United States Cancer Treatment Drugs Market Size (Value and Volume) Status and Forecast (2013-2023)
2 United States Cancer Treatment Drugs Sales, Revenue (Value) and Market Share by Players
2.1 United States Cancer Treatment Drugs Sales and Market Share by Players (2013-2018)
2.2 United States Cancer Treatment Drugs Revenue and Market Share by Players (2013-2018)
2.3 United States Cancer Treatment Drugs Average Price by Players in 2017
2.4 United States Cancer Treatment Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
2.5 Cancer Treatment Drugs Market Competitive Situation and Trends
2.5.1 Cancer Treatment Drugs Market Concentration Rate
2.5.2 Cancer Treatment Drugs Market Share of Top 3 and Top 5 Players in 2017
2.5.3 Mergers & Acquisitions, Expansion
3 United States Cancer Treatment Drugs Sales, Revenue (Value) by Type and Application (2013-2018)
3.1 United States Cancer Treatment Drugs Sales, Revenue, Market Share and Price by Type (2013-2018)
3.1.1 United States Cancer Treatment Drugs Sales and Market Share by Type (2013-2018)
3.1.2 United States Cancer Treatment Drugs Revenue and Market Share by Type (2013-2018)
3.1.3 United States Cancer Treatment Drugs Price by Type (2013-2018)
3.2 United States Cancer Treatment Drugs Sales and Market Share by Application (2013-2018)
3.3 United States Market Cancer Treatment Drugs Sales, Revenue (Million USD), Price and Gross Margin (2013-2018)
4 United States Cancer Treatment Drugs Players Profiles and Sales Data
4.1 Roche
4.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.1.2 Cancer Treatment Drugs Product Types, Application and Specification
4.1.2.1 Type 1
4.1.2.2 Type 2
4.1.3 Roche Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
4.1.4 Main Business/Business Overview
4.1.5 Roche News
4.2 Novartis
4.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.2.2 Cancer Treatment Drugs Product Types, Application and Specification
4.2.2.1 Type 1
4.2.2.2 Type 2
4.2.3 Novartis Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
4.2.4 Main Business/Business Overview
4.2.5 Novartis News
4.3 Celgene
4.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.3.2 Cancer Treatment Drugs Product Types, Application and Specification
4.3.2.1 Type 1
4.3.2.2 Type 2
4.3.3 Celgene Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
4.3.4 Main Business/Business Overview
4.3.5 Celgene News
4.4 Bristol-Myers Squibb
4.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.4.2 Cancer Treatment Drugs Product Types, Application and Specification
4.4.2.1 Type 1
4.4.2.2 Type 2
4.4.3 Bristol-Myers Squibb Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
4.4.4 Main Business/Business Overview
4.4.5 Bristol-Myers Squibb News
4.5 Amgen
4.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.5.2 Cancer Treatment Drugs Product Types, Application and Specification
4.5.2.1 Type 1
4.5.2.2 Type 2
4.5.3 Amgen Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
4.5.4 Main Business/Business Overview
4.5.5 Amgen News
4.6 Johnson & Johnson
4.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.6.2 Cancer Treatment Drugs Product Types, Application and Specification
4.6.2.1 Type 1
4.6.2.2 Type 2
4.6.3 Johnson & Johnson Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
4.6.4 Main Business/Business Overview
4.6.5 Johnson & Johnson News
4.7 Pfizer
4.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.7.2 Cancer Treatment Drugs Product Types, Application and Specification
4.7.2.1 Type 1
4.7.2.2 Type 2
4.7.3 Pfizer Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
4.7.4 Main Business/Business Overview
4.7.5 Pfizer News
4.8 Takeda
4.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.8.2 Cancer Treatment Drugs Product Types, Application and Specification
4.8.2.1 Type 1
4.8.2.2 Type 2
4.8.3 Takeda Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
4.8.4 Main Business/Business Overview
4.8.5 Takeda News
4.9 Eli Lilly
4.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.9.2 Cancer Treatment Drugs Product Types, Application and Specification
9.9.2.1 Type 1
9.9.2.2 Type 2
4.9.3 Eli Lilly Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
4.9.4 Main Business/Business Overview
4.9.5 Eli Lilly News
4.10 AstraZeneca
4.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.10.2 Cancer Treatment Drugs Product Types, Application and Specification
4.10.2.1 Type 1
4.10.2.2 Type 2
4.10.3 AstraZeneca Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
4.10.4 Main Business/Business Overview
4.10.5 AstraZeneca News
4.11 Astellas
4.11.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.11.2 Cancer Treatment Drugs Product Types, Application and Specification
4.11.2.1 Type 1
4.11.2.2 Type 2
4.11.3 Astellas Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
4.11.4 Main Business/Business Overview
4.11.5 Astellas News
4.12 Merck & Co.
4.12.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.12.2 Cancer Treatment Drugs Product Types, Application and Specification
4.12.2.1 Type 1
4.12.2.2 Type 2
4.12.3 Merck & Co. Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
4.12.4 Main Business/Business Overview
4.12.5 Merck & Co. News
4.13 Sanofi
4.13.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.13.2 Cancer Treatment Drugs Product Types, Application and Specification
4.13.2.1 Type 1
4.13.2.2 Type 2
4.13.3 Sanofi Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
4.13.4 Main Business/Business Overview
4.13.5 Sanofi News
4.14 Bayer
4.14.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.14.2 Cancer Treatment Drugs Product Types, Application and Specification
4.14.2.1 Type 1
4.14.2.2 Type 2
4.14.3 Bayer Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
4.14.4 Main Business/Business Overview
4.14.5 Bayer News
4.15 Biogen Idec
4.15.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.15.2 Cancer Treatment Drugs Product Types, Application and Specification
4.15.2.1 Type 1
4.15.2.2 Type 2
4.15.3 Biogen Idec Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
4.15.4 Main Business/Business Overview
4.15.5 Biogen Idec News
4.16 Eisai
4.16.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.16.2 Cancer Treatment Drugs Product Types, Application and Specification
4.16.2.1 Type 1
4.16.2.2 Type 2
4.16.3 Eisai Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
4.16.4 Main Business/Business Overview
4.16.5 Eisai News
4.17 Teva
4.17.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.17.2 Cancer Treatment Drugs Product Types, Application and Specification
4.17.2.1 Type 1
4.17.2.2 Type 2
4.17.3 Teva Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
4.17.4 Main Business/Business Overview
4.17.5 Teva News
4.18 Otsuka
4.18.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.18.2 Cancer Treatment Drugs Product Types, Application and Specification
4.18.2.1 Type 1
4.18.2.2 Type 2
4.18.3 Otsuka Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
4.18.4 Main Business/Business Overview
4.18.5 Otsuka News
4.19 Merck KGaA
4.19.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.19.2 Cancer Treatment Drugs Product Types, Application and Specification
4.19.2.1 Type 1
4.19.2.2 Type 2
4.19.3 Merck KGaA Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
4.19.4 Main Business/Business Overview
4.19.5 Merck KGaA News
4.20 Ipsen
4.20.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.20.2 Cancer Treatment Drugs Product Types, Application and Specification
4.20.2.1 Type 1
4.20.2.2 Type 2
4.20.3 Ipsen Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
4.20.4 Main Business/Business Overview
4.20.5 Ipsen News
4.21 AbbVie
4.21.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.21.2 Cancer Treatment Drugs Product Types, Application and Specification
4.21.2.1 Type 1
4.21.2.2 Type 2
4.21.3 AbbVie Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
4.21.4 Main Business/Business Overview
4.21.5 AbbVie News
4.22 Gilead Sciences
4.22.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.22.2 Cancer Treatment Drugs Product Types, Application and Specification
4.22.2.1 Type 1
4.22.2.2 Type 2
4.22.3 Gilead Sciences Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
4.22.4 Main Business/Business Overview
4.22.5 Gilead Sciences News
5 United States Cancer Treatment Drugs Market Forecast (2018-2023)
5.1 United States Cancer Treatment Drugs Sales, Revenue and Price Forecast (2018-2023)
5.1.1 United States Cancer Treatment Drugs Sales and Growth Rate Forecast (2018-2023)
5.1.2 United States Cancer Treatment Drugs Revenue and Growth Rate Forecast (2018-2023)
5.1.3 United States Cancer Treatment Drugs Price Trend Forecast (2018-2023)
5.2 United States Cancer Treatment Drugs Sales Forecast by Type (2018-2023)
5.3 United States Cancer Treatment Drugs Sales Forecast by Application (2018-2023)
6 Production Cost Analysis of Cancer Treatment Drugs
6.1 Main Raw Materials of Cancer Treatment Drugs
6.1.1 List of Cancer Treatment Drugs Main Raw Materials
6.1.2 Cancer Treatment Drugs Main Raw Materials Price Analysis
6.1.3 Cancer Treatment Drugs Raw Materials Major Suppliers
6.1.4 Cancer Treatment Drugs Main Raw Materials Market Concentration Rate
6.2 Production Cost Structure of Cancer Treatment Drugs
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Production Expenses
6.3 Cancer Treatment Drugs Manufacturing Process/Method
7 Value Chain, Purchasing Strategy and Downstream Buyers
7.1 Cancer Treatment Drugs Value Chain Analysis
7.2 Upstream Raw Materials Purchasing
7.3 Raw Materials Sources of Cancer Treatment Drugs Major Players in 2017
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Sales Channel
8.1.1 Direct Sales
8.1.2 Indirect Sales
8.1.3 Sales Channel Development Trend
8.2 Product Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Cancer Treatment Drugs Distributors/Traders List in United States
9 Market Influences Factors Analysis
9.1 Changes from the Related Industries
9.2 Substitutes Threat
9.3 Customer Preference Change
9.4 Economic/Political Environmental Change
9.5 Upstream and Downstream Fluctuation
10 Research Findings and Conclusion
11 Appendix
11.1 Methodology
11.2 Data Source
List of Tables and Figures

Figure Picture of Cancer Treatment Drugs
Table Product Specifications of Cancer Treatment Drugs
Figure United States Cancer Treatment Drugs Sales (volume) for Each Type (2013-2023)
Figure United States Cancer Treatment Drugs Sales Market Share by Types in 2017
Table Types of Cancer Treatment Drugs
Figure Product Picture of Chemotherapy
Table Major Players of Chemotherapy
Figure Product Picture of Targeted Therapy
Table Major Players of Targeted Therapy
Figure Product Picture of Immunotherapy
Table Major Players of Immunotherapy
Figure Product Picture of Hormonal Therapy (Biologic Therapy)
Table Major Players of Hormonal Therapy (Biologic Therapy)
Figure Product Picture of Others
Table Major Players of Others
Figure United States Cancer Treatment Drugs Sales Present Situation and Outlook by Applications (2013-2023)
Figure United States Cancer Treatment Drugs Sales Market Share by Applications in 2017
Table Applications of Cancer Treatment Drugs
Figure Blood Cancer Examples
Figure Breast Cancer Examples
Figure Gastrointestinal Cancer Examples
Figure Prostate Cancer Examples
Figure Respiratory/Lung Cancer Examples
Figure Other Cancers Examples
Figure United States Cancer Treatment Drugs Revenue (Million USD) Status and Forecast (2013-2023)
Figure United States Cancer Treatment Drugs Sales (Volume) Status and Forecast (2013-2023)
Table United States Cancer Treatment Drugs Sales by Players (2013-2018)
Table United States Cancer Treatment Drugs Sales Market Share (%) by Players (2013-2018)
Figure United States Cancer Treatment Drugs Sales Market Share by Players in 2016
Figure United States Cancer Treatment Drugs Sales Market Share by Players in 2017
Table United States Cancer Treatment Drugs Revenue (Million USD) by Players (2013-2018)
Table United States Cancer Treatment Drugs Revenue Market Share (%) by Players (2013-2018)
Figure United States Cancer Treatment Drugs Revenue Market Share by Players in 2016
Figure United States Cancer Treatment Drugs Revenue Market Share by Players in 2017
Figure United States Cancer Treatment Drugs Average Price by Players in 2017
Table United States Cancer Treatment Drugs Manufacturing Base Distribution and Sales Area by Players
Table Players Cancer Treatment Drugs Product Types
Figure Cancer Treatment Drugs Market Share of Top 3 Players in 2017
Figure Cancer Treatment Drugs Market Share of Top 5 Players in 2017
Table United States Cancer Treatment Drugs Sales by Type (2013-2018)
Table United States Cancer Treatment Drugs Sales Market Share by Type (2013-2018)
Figure United States Cancer Treatment Drugs Sales Market Share by Type in 2013
Figure United States Cancer Treatment Drugs Sales Market Share by Type in 2017
Table United States Cancer Treatment Drugs Revenue (Million USD) by Type (2013-2018)
Table United States Cancer Treatment Drugs Revenue Market Share by Type (2013-2018)
Figure United States Cancer Treatment Drugs Revenue Market Share by Type in 2013
Figure United States Cancer Treatment Drugs Revenue Market Share by Type in 2017
Table United States Cancer Treatment Drugs Price by Type (2013-2018)
Table United States Cancer Treatment Drugs Sales by Application (2013-2018)
Table United States Cancer Treatment Drugs Sales Market Share by Application (2013-2018)
Figure United States Cancer Treatment Drugs Sales Market Share by Application (2013-2018)
Figure United States Cancer Treatment Drugs Sales Market Share by Application in 2017
Table United States Market Cancer Treatment Drugs Sales, Revenue (Million USD), Price and Gross Margin (2013-2018)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Roche Cancer Treatment Drugs Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Cancer Treatment Drugs Market Share (2012-2017)
Table Celgene Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Celgene Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Celgene Cancer Treatment Drugs Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol-Myers Squibb Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Cancer Treatment Drugs Market Share (2012-2017)
Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Amgen Cancer Treatment Drugs Market Share (2012-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Johnson & Johnson Cancer Treatment Drugs Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Cancer Treatment Drugs Market Share (2012-2017)
Table Takeda Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Takeda Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Takeda Cancer Treatment Drugs Market Share (2012-2017)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Eli Lilly Cancer Treatment Drugs Market Share (2012-2017)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AstraZeneca Cancer Treatment Drugs Market Share (2012-2017)
Table Astellas Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Astellas Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Astellas Cancer Treatment Drugs Market Share (2012-2017)
Table Merck & Co. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck & Co. Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Merck & Co. Cancer Treatment Drugs Market Share (2012-2017)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sanofi Cancer Treatment Drugs Market Share (2012-2017)
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bayer Cancer Treatment Drugs Market Share (2012-2017)
Table Biogen Idec Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biogen Idec Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Biogen Idec Cancer Treatment Drugs Market Share (2012-2017)
Table Eisai Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eisai Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Eisai Cancer Treatment Drugs Market Share (2012-2017)
Table Teva Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Teva Cancer Treatment Drugs Market Share (2012-2017)
Table Otsuka Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Otsuka Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Otsuka Cancer Treatment Drugs Market Share (2012-2017)
Table Merck KGaA Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck KGaA Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Merck KGaA Cancer Treatment Drugs Market Share (2012-2017)
Table Ipsen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ipsen Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Ipsen Cancer Treatment Drugs Market Share (2012-2017)
Table AbbVie Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AbbVie Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AbbVie Cancer Treatment Drugs Market Share (2012-2017)
Table Gilead Sciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Gilead Sciences Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Gilead Sciences Cancer Treatment Drugs Market Share (2012-2017)
Figure United States Cancer Treatment Drugs Sales and Growth Rate Forecast (2018-2023)
Figure United States Cancer Treatment Drugs Revenue and Growth Rate Forecast (2018-2023)
Figure United States Cancer Treatment Drugs Price Trend Forecast (2018-2023)
Table United States Cancer Treatment Drugs Sales Forecast by Type (2018-2023)
Figure United States Cancer Treatment Drugs Sales Market Share Forecast by Type (2018-2023)
Figure United States Cancer Treatment Drugs Sales Market Share Forecast by Type in 2023
Table United States Cancer Treatment Drugs Sales Forecast by Application (2018-2023)
Figure United States Cancer Treatment Drugs Sales Market Share Forecast by Application (2018-2023)
Figure United States Cancer Treatment Drugs Sales Market Share Forecast by Application in 2023
Table Production Base and Market Concentration Rate of Raw Material
Figure Cancer Treatment Drugs Main Raw Materials Price Trend
Table Cancer Treatment Drugs Raw Materials Major Suppliers List
Figure Production Cost Structure of Cancer Treatment Drugs
Figure Cancer Treatment Drugs Manufacturing Process/Method
Figure Cancer Treatment Drugs Value Chain Analysis
Table Raw Materials Sources of Cancer Treatment Drugs Major Players in 2017
Table Major Buyers of Cancer Treatment Drugs
Table Cancer Treatment Drugs Distributors/Traders List in United States
  • Global Cancer Treatment Drugs Market Insights, Forecast to 2025
    Published: 19-Mar-2019        Price: US 3900 Onwards        Pages: 124
    Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others. The classification of cancer treatment drugs includes chemotherapy, targeted therapy, immunotherapy, hormonal therapy and others, and the revenue proportion of chemotherapy in 2016 is about 51%. Cancer treatment drugs are widely used for blood cancer, breast ......
  • Global Hydroxycarbamide Market Insights, Forecast to 2025
    Published: 19-Mar-2019        Price: US 3900 Onwards        Pages: 110
    Hydroxycarbamide, also known as hydroxyurea, is a medication used in sickle-cell disease, chronic myelogenous leukemia, cervical cancer, and polycythemia vera. In sickle-cell disease it decreases the number of attacks. It is taken by mouth. Common side effects include bone marrow suppression, fevers, loss of appetite, psychiatric problems, shortness of breath, and headaches. There is also concern that it increases the risk of later cancers. Use during pregnancy is typically harmful to the ......
  • Global Docetaxel Market Insights, Forecast to 2025
    Published: 15-Mar-2019        Price: US 3900 Onwards        Pages: 118
    Docetaxel is a chemotherapy medication used to treat a number of types of Cancer. This includes breast Cancer, head and neck Cancer, stomach Cancer, Prostate Cancer and non-small-cell lung Cancer. It may be used by itself or along with other chemotherapy medication. It is given by slow injection into a vein. The classification of Docetaxel includes 20 mg/ml, 40 mg/ml and 60 mg/ml. And the proportion of 20 mg/ml in 2017 is about 86% and the proportion is stable from 2013 to 2017. Doc......
  • Global Hydroxycarbamide Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 15-Mar-2019        Price: US 3480 Onwards        Pages: 121
    Hydroxycarbamide, also known as hydroxyurea, is a medication used in sickle-cell disease, chronic myelogenous leukemia, cervical cancer, and polycythemia vera. In sickle-cell disease it decreases the number of attacks. It is taken by mouth. Common side effects include bone marrow suppression, fevers, loss of appetite, psychiatric problems, shortness of breath, and headaches. There is also concern that it increases the risk of later cancers. Use during pregnancy is typically harmful to the......
  • 5-fluorouracil Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 13-Mar-2019        Price: US 3000 Onwards        Pages: 135
    5-fluorouracil Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global 5-fluorouracil industry with a focus on the Chinese market. The report provides key statistics on the market status of the 5-fluorouracil manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Chinese 5-fluorouracil market......
  • Global Lentinan Market Data Survey Report 2013-2025
    Published: 13-Mar-2019        Price: US 1500 Onwards        Pages: 63
    Summary Lentinan is a beta-glucan (a type of polysaccharide) from the mushroom lentinus edodes (shiitake mushroom). It has been studied in Japan as a treatment for cancer. The global Lentinan market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers profile, products & services, sales data of bus......
  • Global Hematological Malignancies Disease Market Data Survey Report 2013-2025
    Published: 12-Mar-2019        Price: US 1500 Onwards        Pages: 76
    Summary The global Hematological Malignancies Disease market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers profile, products & services, sales data of business Global market size by Major Application Global market size by Major Type Key manufacturers are included based ......
  • Global Capecitabine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 12-Mar-2019        Price: US 3480 Onwards        Pages: 119
    Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Scope of the Report: Capecitabine is a prescription medication used to treat breast cancer and cancer of the colon or rectum. Capecitabine belongs to a group of drugs called an......
  • Global Cytotoxic Drug Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 12-Mar-2019        Price: US 3480 Onwards        Pages: 117
    Cytotoxic drugs inhibit or prevent the function of cells. Cytotoxic drugs are primarily used to treat cancer, frequently as part of a chemotherapy regime. Recently, their uses have expanded to treat certain skin conditions (e.g., psoriasis), rheumatoid and juvenile rheumatoid arthritis, and steroid-resistant muscle conditions. The most common forms of cytotoxic drugs are known as antineoplastic. The terms ‘antineoplastic' and ‘cytotoxic' are often used interchangeably. Scope of th......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs